(Q38165871)

30 August 2017

Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma (English)

1 reference

30 August 2017

pancreaticoduodenectomy

0 references

1 reference

Cynthia E Weber

1

1 reference

30 August 2017

Eileen A Bock

2

1 reference

30 August 2017

Michael G Hurtuk

3

1 reference

30 August 2017

Gerard J Abood

4

1 reference

30 August 2017

Jack Pickleman

5

1 reference

30 August 2017

Margo Shoup

6

1 reference

30 August 2017

Gerard V Aranha

7

1 reference

30 August 2017

23 November 2013

1 reference

Journal of Gastrointestinal Surgery

30 August 2017

1 reference

30 August 2017

18

1 reference

30 August 2017

2

1 reference

30 August 2017

340-347

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-013-2388-x

30 August 2017

0 references

cites work

Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic factors after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Critical analysis of a large series of pancreaticogastrostomy after pancreaticoduodenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Hospital volume and late survival after cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2388-X

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

21 January 2018

1 reference

12 December 2020

Prognosis factors in carcinoma of the head of the pancreas

1 reference

12 December 2020

The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer

1 reference

12 December 2020

A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma

1 reference

12 December 2020

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis

1 reference

12 December 2020

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer

1 reference

12 December 2020

Assessment of complications according to the Clavien-Dindo classification after distal pancreatectomy.

1 reference

12 December 2020

Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma

1 reference

12 December 2020

Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis

1 reference

12 December 2020

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

1 reference

12 December 2020

10.1007/S11605-013-2388-X

Identifiers

DOI

1 reference

30 August 2017

1 reference